UPDATED Apr 25, 2024
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2330 | NT$782.00 | 4.3% | 55.8% | NT$20.3t | NT$912.98 | PE23.7x | E16.1% | 1.8% | Semiconductors | ||
AZN | UK£120.26 | 9.9% | 2.4% | UK£186.4b | UK£129.55 | PE36.8x | E16.5% | 2.1% | Pharmaceuticals & Biotech | ||
NOVN | CHF90.00 | 5.2% | -1.2% | CHF183.6b | CHF98.99 | PE22.1x | E9.9% | 3.7% | Pharmaceuticals & Biotech | ||
ROG | CHF218.80 | -1.5% | -22.0% | CHF176.4b | CHF279.39 | PE15.2x | E8.6% | 4.4% | Pharmaceuticals & Biotech | ||
AIR | €158.52 | -0.9% | 24.7% | €125.4b | €177.35 | PE32x | E18.4% | 1.1% | Capital Goods | ||
SLB | US$49.44 | -2.9% | 3.1% | US$70.7b | US$67.11 | PE16.3x | E13.1% | 2.2% | Energy | ||
ZURN | CHF442.60 | -1.3% | 2.5% | CHF63.7b | CHF459.23 | PE16.1x | E8.6% | 5.9% | Insurance | ||
NTES | US$94.12 | 1.8% | 6.3% | US$60.7b | US$132.85 | PE14.9x | E7.9% | 2.7% | Media | ||
2454 | NT$1,005.00 | 1.2% | 51.1% | NT$1.6t | NT$1,199.29 | PE20.8x | E14.0% | 6.0% | Semiconductors | ||
BBRI | Rp4,830.00 | -8.4% | -5.3% | Rp776.6t | Rp6,591.96 | PB2.5x | E11.9% | 6.6% | Banks | ||
BMRI | Rp6,750.00 | 0.4% | 30.4% | Rp648.7t | Rp7,544.68 | PB2.4x | E9.4% | 5.2% | Banks | ||
2020 | HK$90.00 | 7.4% | -7.0% | HK$254.9b | HK$111.78 | PE23.1x | E13.0% | 2.5% | Consumer Durables | ||
EVO | kr1,244.50 | -2.8% | -8.9% | kr262.6b | kr1,490.30 | PE20.6x | E13.5% | 2.5% | Consumer Services | ||
300274 | CN¥99.27 | 4.3% | -11.9% | CN¥145.8b | CN¥131.17 | PE14.5x | E11.1% | 1.0% | Capital Goods | ||
ALL | AU$40.20 | -0.3% | 6.0% | AU$25.5b | AU$47.49 | PE17.5x | E5.1% | 1.7% | Consumer Services | ||
KCHOL | ₺217.00 | -1.3% | 186.8% | ₺541.2b | ₺215.07 | PE7.6x | E26.5% | 3.7% | Capital Goods | ||
SOON | CHF251.70 | 1.5% | -10.7% | CHF15.0b | CHF270.88 | PE25x | E10.7% | 1.8% | Healthcare | ||
300015 | CN¥12.63 | 4.0% | -44.3% | CN¥117.8b | CN¥21.32 | PE33.9x | E18.6% | 0.6% | Healthcare | ||
2027 | CN¥6.85 | -1.4% | 6.4% | CN¥98.9b | CN¥8.02 | PE23.2x | E19.0% | 6.1% | Media | ||
JMT | €19.03 | 7.0% | -16.9% | €11.7b | €23.39 | PE15.8x | E7.3% | 3.4% | Consumer Retailing | ||
HTHT | US$39.74 | 6.4% | -12.8% | US$12.5b | US$52.39 | PE22.1x | E10.7% | 3.1% | Consumer Services | ||
300122 | CN¥34.83 | -14.0% | -35.8% | CN¥83.4b | CN¥62.47 | PE11.1x | E23.8% | 2.3% | Pharmaceuticals & Biotech | ||
600845 | CN¥39.77 | 6.1% | -11.6% | CN¥80.8b | CN¥49.57 | PE36.1x | E21.4% | 2.5% | Software | ||
2050 | CN¥22.16 | 6.4% | -5.1% | CN¥79.4b | CN¥31.83 | PE25.6x | E19.2% | 1.1% | Capital Goods |